Pathogen Reduction of Platelets: Patient Safety and FDA Platelet Bacterial Guidance Compliance
Runtime: ~16 minutes
Pathogen Reduction of Platelets: Guidance Compliance and Implementation
Runtime: ~13 minutes
Updating a Software Model to Estimate the Cost and Shelf Life Implications of New Platelet Technologies
Runtime: ~16 minutes
Implementing Pathogen Reduced (PR) INTERCEPT Platelets and Pediatric Considerations
Runtime: ~17 minutes
Preparing Our Blood Supply for the Next Pandemic with Dr. Susan Stramer
Runtime: ~25 minutes
Rx Only. For CONTRAINDICATIONS and WARNINGS, click here. See package insert for full prescribing information – available on the resource page. There is no pathogen inactivation process that has been shown to eliminate all pathogens. ©2021 Cerus Corporation. All Rights Reserved. INTERCEPT, INTERCEPT Blood System and CERUS are registered trademarks of Cerus Corporation. This site is intended for US audiences only. MKT-EN 00401 v2.0